Research Paper Volume 15, Issue 16 pp 8408—8432

SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma

class="figure-viewer-img"

Figure 5. Somatic mutation landscape of HCC based on SART3. (A) Waterfall plots demonstrate the HCC somatic mutation landscape in the SART3high and SART3low in TCGA and Guangxi cohort. In the TCGA cohort, (B) SART3 expression between TP53 mutation and TP53 wild group, (C) survival analysis of TP53 mutation group and TP53 wild group, (D) SART3 expression between CTNNB1 mutation and wild group, (E) survival analysis of CTNNB1 mutation group and CTNNB1 wild group. (F) Immunohistochemical staining intensity of SART3 between TP53 mutation and TP53 wild group in the Guangxi cohort. (G) Representative images of immunohistochemistry.